Prot# RIVAROXHFA1001 (Impact 12980): A Randomized, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Rivaroxaban in Subjects with Acute (Open-Label, Active-Controlled) or Chronic (Double-Blind, Placebo-Controlled) Congest